ImmunityBio Inc. Common Stock vs Teck Resources — how do they compare? ImmunityBio Inc. Common Stock trades at $10.02 (market cap $10.33B), while Teck Resources trades at $64.84 (market cap $32.19B). The key difference: Teck Resources is far larger — about 3.1× ImmunityBio Inc. Common Stock's market cap, and Teck Resources pays a 0.54% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Teck Resources for 13 Days on average.
| IBRX | TECK | |
|---|---|---|
Market Cap | $10.33B | $32.19B |
Volume | 11,745,198 | 1,489,977 |
Sector | Health | Basic Materials |
52-Week High | $11.55 | $71.97 |
52-Week Low | $1.98 | $38.23 |
Typical Hold Time | 0 Days | 13 Days |
Enterprise Value | $10.79B | $34.82B |
Dividend Yield | — | 0.54% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Teck Resources is a mining company focused on producing metals and minerals, including copper and zinc. Its operations supply materials used in infrastructure, manufacturing, and energy-related industries.
Read more on TECK →